Invention Grant
- Patent Title: Bioconversion of levulinic acid in genetically engineered hosts
-
Application No.: US16135123Application Date: 2018-09-19
-
Publication No.: US10934563B2Publication Date: 2021-03-02
- Inventor: Brian Frederick Pfleger , Jacqueline Marie Rand , Christopher Robert Mehrer , Matthew Ryan Incha
- Applicant: Wisconsin Alumni Research Foundation
- Applicant Address: US WI Madison
- Assignee: Wisconsin Alumni Research Foundation
- Current Assignee: Wisconsin Alumni Research Foundation
- Current Assignee Address: US WI Madison
- Agency: DeWitt LLP
- Agent Joseph T. Leone, Esq.
- Main IPC: C12P7/16
- IPC: C12P7/16 ; C12N15/62 ; C12N15/52 ; C12N15/64 ; C12N15/66 ; C12N9/10 ; C12N9/18 ; C12N15/69 ; C12N15/63 ; C12P7/26
Abstract:
Described is a recombinant expression vector that enables a cell transformed to contain and express the vector to use levulinic acid as a carbon source, thereby converting levulnic acid into 2-butanne. Also described are genetically modified cells transformed to contain and express the vector and methods of using the cells to produce 2-butanone from a medium containing levulinic acid.
Public/Granted literature
- US20190085362A1 BIOCONVERSION OF LEVULINIC ACID IN GENETICALLY ENGINEERED HOSTS Public/Granted day:2019-03-21
Information query
